Complete Filing Data
Enact Holdings, Inc. reported Stockholders Equity of $5.36 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Enact Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenues | $1.24B | $1.20B | $1.15B | $1.10B | $1.12B | $1.11B | $978.9M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $177.3M | $22.9M | $152.3M | -$466.3M | -$125.1M | $114.9M | $120.0M |
| Interest Expense | $49.9M | $51.2M | $51.9M | $51.7M | $51.0M | $18.2M | $0.00 |
| Income Tax Expense Benefit | $184.6M | $190.0M | $186.0M | $194.1M | $148.5M | $102.0M | $155.8M |
| Comprehensive Income Net Of Tax | $851.6M | $711.0M | $817.9M | $237.8M | $421.6M | $485.4M | $797.6M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $858.8M | $878.1M | $851.5M | $898.2M | $695.2M | $472.4M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$5.7M | $13.0K | $4.0K | $159.0K | -$7.0K | $0.00 | $0.00 |
| Policy Acquisition Costs And Operating Expenses | $231.5M | $215.0M | $195.8M | ||||
| Net Income Loss Available To Common Stockholders Basic | $674.2M | $688.1M | $665.5M | $704.2M | $546.7M | $370.4M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $183.0M | $22.9M | $152.3M | -$466.5M | -$125.1M | $114.9M | $120.0M |
| Deferred Income Tax Expense Benefit | $7.8M | $4.5M | -$1.8M | -$2.3M | -$1.4M | $11.1M | $56.7M |
| Deferred Income Tax Assets Net | $20.0M | $65.0M | $88.5M | $127.5M | $0.00 | ||
| Net Income Loss | $674.2M | $688.1M | $665.5M | $546.7M | $370.4M | $677.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | $311.5M | $304.9M | $306.8M | $309.6M | $298.8M | $291.6M | $299.0M | $277.5M | $280.9M | $275.1M | $273.5M | $269.6M | $280.3M | $276.1M | $288.6M | $284.3M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $62.6M | $48.1M | $55.0M | $134.3M | $1.2M | -$7.1M | -$55.1M | -$25.0M | $62.5M | -$134.1M | -$152.3M | -$224.3M | -$25.9M | $22.9M | -$71.7M | $30.8M |
| Interest Expense | $12.9M | $12.3M | $12.3M | $12.3M | $13.6M | $13.0M | $12.9M | $12.9M | $13.1M | $12.9M | $12.8M | $12.8M | $12.8M | $12.7M | $12.7M | $5.5M |
| Income Tax Expense Benefit | $46.3M | $46.7M | $45.6M | $48.8M | $51.2M | $44.9M | $48.9M | $46.1M | $48.5M | $53.7M | $56.2M | $45.3M | $37.4M | $35.9M | $33.9M | $37.5M |
| Comprehensive Income Net Of Tax | $226.1M | $215.9M | $220.8M | $315.0M | $184.8M | $153.9M | $109.1M | $143.0M | $238.5M | $56.9M | $52.4M | -$59.6M | $111.3M | $153.7M | $53.4M | $168.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $209.8M | $214.5M | $211.4M | $229.5M | $234.8M | $205.9M | $213.1M | $214.1M | $224.5M | $244.6M | $260.9M | $209.9M | $174.6M | $166.7M | $159.0M | $175.5M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.3M | -$114.0K | -$3.9M | $2.0K | $0.00 | $2.0K | $12.0K | -$1.0K | -$8.0K | $44.0K | $64.0K | $29.0K | $0.00 | $0.00 | $0.00 | |
| Policy Acquisition Costs And Operating Expenses | $50.5M | $50.6M | $50.1M | $53.1M | $54.0M | $50.9M | $52.3M | $51.9M | $51.7M | $54.5M | $58.2M | $54.3M | $55.2M | $63.1M | $57.6M | $55.0M |
| Net Income Loss Available To Common Stockholders Basic | $163.5M | $167.8M | $165.8M | $180.7M | $183.7M | $161.0M | $164.2M | $168.0M | $176.0M | $191.0M | $204.7M | $164.6M | $137.2M | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $63.8M | $48.3M | $58.9M | $134.3M | $1.2M | -$7.1M | -$55.1M | -$25.0M | $62.5M | -$134.1M | -$152.4M | -$224.3M | ||||
| Deferred Income Tax Expense Benefit | $4.5M | $1.0M | $2.6M | $2.9M | $2.3M | |||||||||||
| Deferred Income Tax Assets Net | $23.2M | $32.5M | $44.4M | $50.1M | $89.1M | $89.4M | $119.7M | $119.1M | $107.9M | $135.2M | $98.7M | $56.1M | ||||
| Net Income Loss | $204.7M | $164.6M | $137.2M | $130.8M | $125.1M | $138.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $5.36B | $5.00B | $4.63B | $4.10B | $4.11B | $3.88B | $3.83B | $3.27B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $582.5M | $599.4M | $615.7M | $513.8M | $425.8M | $452.8M | $585.1M | $159.1M |
| Gain Loss On Investments | -$16.3M | -$22.8M | -$14.0M | -$2.0M | -$2.1M | -$3.3M | $718.0K | |
| Amortization Of Deferred Policy Acquisition Costs And Intangibles | $9.2M | $9.7M | $10.7M | $12.4M | $14.7M | $20.9M | $15.1M | |
| Liability For Claims And Claims Adjustment Expense | $572.5M | $524.7M | $518.2M | $519.0M | $641.3M | $555.7M | $235.1M | $297.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$16.9M | -$16.3M | $101.9M | $87.9M | -$27.0M | -$132.3M | $426.0M | |
| Accretion Amortization Of Discounts And Premiums Investments | $14.0M | $11.6M | $6.5M | $3.2M | $8.5M | $5.4M | $2.6M | |
| Retained Earnings Accumulated Deficit | $3.68B | $3.13B | $2.55B | $2.10B | $1.65B | $1.30B | ||
| Premiums Receivable At Carrying Value | $46.1M | $53.0M | $45.1M | $41.7M | $42.3M | $46.5M | ||
| Other Liabilities | $129.7M | $143.0M | $145.2M | $143.7M | $130.6M | $133.3M | ||
| Other Assets | $116.0M | $102.5M | $88.3M | $76.4M | $73.1M | $48.8M | ||
| Long Term Debt | $744.5M | $743.1M | $745.4M | $742.8M | $740.4M | $738.2M | ||
| Liabilities And Stockholders Equity | $6.89B | $6.52B | $6.19B | $5.71B | $5.87B | $5.65B | ||
| Liabilities | $1.54B | $1.53B | $1.56B | $1.61B | $1.76B | $1.77B | ||
| Deferred Policy Acquisition Costs | $22.2M | $23.8M | $25.0M | $26.1M | $27.2M | $28.9M | ||
| Debt Securities Available For Sale Excluding Accrued Interest | $6.05B | $5.62B | $5.27B | $4.88B | $5.27B | $5.05B | ||
| Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss | $6.08B | $5.88B | $5.56B | $5.37B | $5.16B | $4.78B | ||
| Common Stock Value | $1.4M | $1.5M | $1.6M | $1.6M | $1.6M | $1.6M | ||
| Cash And Cash Equivalents At Carrying Value | $582.5M | $599.4M | $615.7M | $513.8M | $425.8M | $452.8M | ||
| Assets | $6.89B | $6.52B | $6.19B | $5.71B | $5.87B | $5.65B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$30.1M | -$207.5M | -$230.4M | -$382.7M | $83.6M | $208.4M | ||
| Accrued Investment Income Receivable | $56.1M | $49.6M | $41.6M | $35.8M | $31.1M | $29.2M | ||
| Short Term Investments | $0.00 | $3.4M | $20.2M | $3.0M | $0.00 | |||
| Investments | $6.05B | $5.63B | $5.29B | $4.89B | $5.27B | |||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$10.9M | $0.00 | $0.00 | ||||
| Dividends Common Stock | $120.8M | $111.7M | $213.0M | $250.8M | $200.3M | $437.4M | $250.0M | |
| Premiums Receivable Allowance For Doubtful Accounts | $893.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $5.32B | $5.22B | $5.12B | $5.04B | $4.83B | $4.71B | $4.46B | $4.38B | $4.30B | $4.12B | $4.08B | $4.05B | $4.20B | $4.09B | $3.94B | $3.77B | $4.03B | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $543.6M | $613.0M | $635.3M | $673.4M | $699.0M | $614.3M | $678.0M | $691.4M | $621.6M | $535.8M | $583.9M | $440.2M | $451.6M | $435.3M | $431.3M | $556.7M | |||
| Gain Loss On Investments | -$2.8M | -$7.3M | -$3.2M | -$1.2M | -$7.7M | -$6.7M | -$23.0K | -$13.0M | -$122.0K | -$42.0K | -$381.0K | -$339.0K | $580.0K | -$1.8M | -$956.0K | -$1.6M | |||
| Amortization Of Deferred Policy Acquisition Costs And Intangibles | $2.3M | $2.2M | $2.4M | $2.6M | $2.3M | $2.3M | $2.8M | $2.6M | $2.6M | $3.3M | $3.2M | $3.1M | $3.7M | $3.6M | $3.8M | $3.9M | |||
| Liability For Claims And Claims Adjustment Expense | $572.1M | $551.9M | $542.5M | $510.4M | $508.1M | $531.4M | $501.1M | $490.2M | $501.4M | $510.2M | $558.9M | $625.3M | $648.4M | $624.3M | $603.5M | $474.7M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $35.8M | -$1.4M | $107.8M | $14.3M | -$21.5M | ||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $3.4M | $2.4M | $657.0K | $961.0K | $2.8M | ||||||||||||||
| Retained Earnings Accumulated Deficit | $3.53B | $3.40B | $3.26B | $2.99B | $2.84B | $2.69B | $2.53B | $2.40B | $2.25B | $2.16B | $1.99B | $1.81B | $1.70B | ||||||
| Premiums Receivable At Carrying Value | $48.6M | $44.1M | $46.5M | $48.8M | $48.7M | $43.9M | $44.3M | $43.5M | $42.0M | $40.3M | $41.0M | $40.4M | $43.4M | ||||||
| Other Liabilities | $147.0M | $153.4M | $208.7M | $186.3M | $143.2M | $173.5M | $136.1M | $139.1M | $112.0M | $140.4M | $154.7M | $141.1M | $129.5M | ||||||
| Other Assets | $114.1M | $107.9M | $103.4M | $100.7M | $98.9M | $126.6M | $82.2M | $80.4M | $77.0M | $69.0M | $67.6M | $103.2M | $48.6M | ||||||
| Long Term Debt | $744.1M | $743.8M | $743.4M | $742.7M | $742.4M | $746.1M | $744.8M | $744.1M | $743.5M | $742.2M | $741.6M | $741.0M | $739.8M | ||||||
| Liabilities And Stockholders Equity | $6.88B | $6.77B | $6.72B | $6.60B | $6.35B | $6.30B | $6.00B | $5.92B | $5.84B | $5.72B | $5.76B | $5.79B | $5.99B | ||||||
| Liabilities | $1.56B | $1.55B | $1.60B | $1.56B | $1.52B | $1.59B | $1.54B | $1.55B | $1.55B | $1.61B | $1.68B | $1.74B | $1.79B | ||||||
| Deferred Policy Acquisition Costs | $22.5M | $22.9M | $23.3M | $24.2M | $24.6M | $24.9M | $25.6M | $25.8M | $26.0M | $26.3M | $26.7M | $27.0M | $27.8M | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest | $6.07B | $5.90B | $5.82B | $5.65B | $5.33B | $5.35B | $4.99B | $4.92B | $4.93B | $4.88B | $4.91B | $5.09B | $5.38B | ||||||
| Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss | $6.12B | $6.01B | $5.99B | $5.78B | $5.63B | $5.65B | $5.49B | $5.35B | $5.34B | $5.42B | $5.28B | $5.27B | $5.21B | ||||||
| Common Stock Value | $1.5M | $1.5M | $1.5M | $1.5M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | ||||||
| Cash And Cash Equivalents At Carrying Value | $543.6M | $613.0M | $635.3M | $673.4M | $699.0M | $614.3M | $678.0M | $691.4M | $621.6M | $535.8M | $583.9M | $440.2M | $451.6M | ||||||
| Assets | $6.88B | $6.77B | $6.72B | $6.60B | $6.35B | $6.30B | $6.00B | $5.92B | $5.84B | $5.72B | $5.76B | $5.79B | $5.99B | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$41.8M | -$104.3M | -$152.5M | -$102.0M | -$236.3M | -$237.5M | -$400.3M | -$345.2M | -$320.2M | -$427.1M | -$293.0M | -$140.7M | $134.0M | ||||||
| Accrued Investment Income Receivable | $53.9M | $53.3M | $49.7M | $46.0M | $45.3M | $43.5M | $42.1M | $37.7M | $35.9M | $35.9M | $33.1M | $32.6M | $31.4M | ||||||
| Short Term Investments | $2.0M | $3.0M | $3.7M | $1.6M | $12.3M | $10.0M | $18.2M | $10.8M | $2.2M | $2.4M | $12.5M | $0.00 | |||||||
| Investments | $6.07B | $5.90B | $5.82B | $5.65B | $5.34B | $5.36B | $5.01B | $4.93B | $4.93B | $4.88B | $5.39B | $5.05B | |||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | -$10.9M | $0.00 | $0.00 | |||||||||||||
| Dividends Common Stock | $435.7M | ||||||||||||||||||
| Premiums Receivable Allowance For Doubtful Accounts | $924.0K | $894.0K | $868.0K | $873.0K | $834.0K | $856.0K | $867.0K | $948.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $19.0M | $18.8M | $15.3M | $9.9M | $1.5M | $0.00 | $0.00 |
| Proceeds From Sale Of Available For Sale Securities Debt | $763.6M | $554.0M | $423.4M | $534.7M | $498.8M | $278.5M | $257.7M |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $911.6M | $735.4M | $396.2M | $470.8M | $713.0M | $527.1M | $359.3M |
| Payments To Acquire Available For Sale Securities Debt | $1.90B | $1.61B | $1.02B | $1.22B | $1.58B | $1.94B | $951.3M |
| Net Cash Provided By Used In Operating Activities | $724.5M | $686.3M | $632.0M | $560.5M | $572.1M | $704.4M | $500.0M |
| Net Cash Provided By Used In Investing Activities | -$226.4M | -$320.5M | -$229.4M | -$220.3M | -$398.8M | -$1.14B | $176.0M |
| Net Cash Provided By Used In Financing Activities | -$515.1M | -$382.0M | -$300.7M | -$252.3M | -$200.3M | $300.3M | -$250.0M |
| Increase Decrease In Unearned Premiums | -$23.0M | -$34.7M | -$53.4M | -$43.6M | -$60.6M | -$76.5M | -$38.3M |
| Increase Decrease In Premiums Receivable | -$6.9M | $8.0M | $3.3M | -$528.0K | -$4.2M | $5.3M | $1.2M |
| Increase Decrease In Other Operating Liabilities | $7.4M | -$10.4M | $494.0K | $14.2M | $1.1M | $71.1M | -$20.1M |
| Increase Decrease In Other Operating Assets | $16.7M | -$1.5M | -$1.2M | $2.3M | $7.3M | -$5.0M | $31.6M |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $47.8M | $6.5M | -$817.0K | -$122.3M | $85.6M | $320.6M | -$62.8M |
| Increase Decrease In Deferred Policy Acquisition Costs | $5.2M | $5.8M | $6.1M | $6.7M | $7.3M | $12.7M | $10.6M |
| Increase Decrease In Accrued Investment Income Receivable | $6.5M | $8.0M | $5.7M | $4.8M | $1.9M | $5.1M | $2.2M |
| Payments Of Dividends | $120.8M | $111.7M | $213.0M | $250.8M | $200.3M | $437.4M | $250.0M |
| Payments For Repurchase Of Common Stock | $382.4M | $244.0M | $87.8M | $1.5M | $0.00 | $0.00 | |
| Payments For Proceeds From Short Term Investments | -$3.4M | -$16.8M | $16.7M | $3.1M | $0.00 | $0.00 | |
| Payments For Proceeds From Other Investing Activities | $8.3M | $15.6M | $13.9M | $0.00 | $0.00 | ||
| Proceeds From Issuance Of Long Term Debt | $0.00 | $749.6M | $0.00 | $0.00 | $0.00 | $737.7M | $0.00 |
| Payments To Acquire Equity Method Investments | $5.5M | $0.00 | $6.5M | $27.3M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.9M | $3.9M | $2.2M | $2.7M | $0.00 |
| Proceeds From Sale Of Available For Sale Securities Debt | $142.6M | $190.2M | $19.5M | $90.4M | $230.4M |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $276.5M | $104.4M | $136.8M | $114.2M | $161.3M |
| Payments To Acquire Available For Sale Securities Debt | $505.0M | $409.2M | $121.1M | $351.1M | $527.7M |
| Net Cash Provided By Used In Operating Activities | $226.7M | $187.3M | $119.3M | $160.8M | $127.0M |
| Net Cash Provided By Used In Investing Activities | -$89.6M | -$113.5M | $33.5M | -$146.5M | -$148.5M |
| Net Cash Provided By Used In Financing Activities | -$101.3M | -$75.2M | -$45.0M | $0.00 | $0.00 |
| Increase Decrease In Unearned Premiums | -$7.2M | -$10.4M | -$14.0M | -$9.9M | -$26.2M |
| Increase Decrease In Premiums Receivable | -$6.6M | -$1.1M | $267.0K | -$1.9M | -$4.0M |
| Increase Decrease In Other Operating Liabilities | $34.9M | $13.1M | -$31.6M | $11.8M | -$25.2M |
| Increase Decrease In Other Operating Assets | $904.0K | -$447.0K | -$986.0K | -$2.9M | $2.1M |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $17.8M | $13.3M | -$17.6M | -$16.0M | $47.8M |
| Increase Decrease In Deferred Policy Acquisition Costs | $1.2M | $1.4M | $1.5M | $1.6M | $1.8M |
| Increase Decrease In Accrued Investment Income Receivable | $59.0K | $1.9M | $101.0K | $1.5M | -$389.0K |
| Payments Of Dividends | $28.1M | $25.5M | $22.8M | $0.00 | |
| Payments For Repurchase Of Common Stock | $65.3M | $49.7M | $22.2M | $0.00 | |
| Payments For Proceeds From Short Term Investments | $322.0K | -$10.3M | -$863.0K | $0.00 | |
| Payments For Proceeds From Other Investing Activities | $2.9M | $3.6M | $2.6M | $0.00 | |
| Proceeds From Issuance Of Long Term Debt | |||||
| Payments To Acquire Equity Method Investments | $5.5M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 148.4M | 156.3M | 160.9M | 162.8M | 162.8M | 162.8M | 162.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 149.3M | 157.6M | 161.8M | 163.3M | 162.9M | 162.8M | 162.8M |
| Earnings Per Share Diluted | $4.52 | $4.37 | $4.11 | $4.31 | $3.36 | $2.27 | $4.16 |
| Earnings Per Share Basic | $4.54 | $4.40 | $4.14 | $4.32 | $3.36 | $2.27 | $4.16 |
| Common Stock Shares Authorized | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | |
| Common Stock Par Or Stated Value Per Share | $10.00 | $10.00 | $10.00 | $10.00 | $10.00 | $10.00 | |
| Common Stock Shares Issued | 142.2M | 152.3M | 159.3M | 162.8M | 162.84B | 162.8M | |
| Common Stock Shares Outstanding | 142.2M | 152.3M | 159.3M | 162.8M | 162.8M | 162.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 147.4M | 149.9M | 151.8M | 155.6M | 157.2M | 158.8M | 160.1M | 161.3M | 162.4M | 162.8M | 162.8M | 162.8M | 162.8M | 162.8M | 162.8M | 162.8M | |
| Weighted Average Number Of Diluted Shares Outstanding | 148.3M | 150.7M | 152.9M | 157.0M | 158.6M | 160.1M | 161.1M | 162.2M | 163.2M | 163.4M | 163.2M | 163.1M | 162.9M | 162.8M | 162.8M | 162.8M | |
| Earnings Per Share Diluted | $1.10 | $1.11 | $1.08 | $1.15 | $1.16 | $1.01 | $1.02 | $1.04 | $1.08 | $1.17 | $1.25 | $1.01 | $0.84 | $0.80 | $0.77 | $0.85 | |
| Earnings Per Share Basic | $1.11 | $1.12 | $1.09 | $1.16 | $1.17 | $1.01 | $1.03 | $1.04 | $1.08 | $1.17 | $1.26 | $1.01 | $0.84 | $0.80 | $0.77 | $0.85 | |
| Common Stock Shares Authorized | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Common Stock Shares Issued | 145.6M | 148.4M | 150.8M | 154.5M | 156.1M | 157.7M | 160.0M | 160.2M | 161.9M | 162.8M | 162.8M | 162.8M | 162.8M | 162.8M | |||
| Common Stock Shares Outstanding | 145.6M | 148.4M | 150.8M | 154.5M | 156.1M | 157.7M | 160.0M | 160.2M | 161.9M | 162.8M | 162.8M | 162.8M | 162.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Premiums Earned Net | $980.5M | $980.1M | $957.1M | $939.5M | $974.9M | $971.4M | $857.0M |
| Policyholder Benefits And Claims Incurred Net | $109.5M | $38.7M | $27.2M | -$94.2M | $125.5M | $379.8M | $49.9M |
| Other Income | $5.4M | $3.9M | $3.3M | $2.3M | $3.8M | $5.6M | $4.2M |
| Net Investment Income | $266.2M | $240.6M | $207.4M | $155.3M | $141.2M | $132.8M | $116.9M |
| Benefits Losses And Expenses | $377.0M | $323.7M | $302.2M | $196.8M | $422.6M | $634.0M | $260.7M |
| Amortization Of Financing Costs | $1.4M | $2.0M | $2.6M | $2.4M | $2.3M | $0.00 | $0.00 |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.4M | $14.3M | $9.9M | $1.5M | |||
| Unearned Premiums | $91.6M | $114.7M | $149.3M | $202.7M | $246.3M | $306.9M | |
| Additional Paid In Capital | $1.71B | $2.08B | $2.31B | $2.38B | $2.37B | $2.37B | |
| Stock Repurchased And Retired During Period Value | $382.4M | $244.0M | $87.8M | $1.5M | |||
| Dividends | |||||||
| Other Noncash Income Expense | $0.00 | $0.00 | $21.0K | -$907.0K | -$6.7M | -$6.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premiums Earned Net | $244.7M | $245.3M | $244.8M | $249.1M | $244.6M | $240.7M | $243.3M | $238.5M | $235.1M | $235.1M | $237.4M | $234.3M | $243.1M | $242.5M | $252.5M | $251.4M |
| Policyholder Benefits And Claims Incurred Net | $35.9M | $25.3M | $30.5M | $12.2M | -$16.8M | $19.5M | $17.8M | -$4.1M | -$11.0M | -$40.3M | -$61.6M | -$10.4M | $34.1M | $30.0M | $55.4M | $44.5M |
| Other Income | $990.0K | $1.1M | $2.2M | $720.0K | $2.2M | $402.0K | $760.0K | $1.1M | $612.0K | $564.0K | $760.0K | $502.0K | $671.0K | $705.0K | $1.7M | $1.3M |
| Net Investment Income | $68.6M | $65.9M | $63.0M | $61.1M | $59.8M | $57.1M | $55.0M | $50.9M | $45.3M | $39.5M | $35.8M | $35.1M | $36.0M | $34.7M | $35.3M | $33.2M |
| Benefits Losses And Expenses | $101.6M | $90.4M | $95.4M | $80.1M | $64.0M | $85.7M | $85.9M | $63.4M | $56.4M | $30.4M | $12.7M | $59.7M | $105.7M | $109.4M | $129.6M | $108.9M |
| Amortization Of Financing Costs | $349.0K | $674.0K | $630.0K | $588.0K | $549.0K | |||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -$4.5M | $4.9M | $2.7M | $4.1M | $3.2M | $2.2M | $2.4M | $2.3M | $2.7M | $221.0K | ||||||
| Unearned Premiums | $96.0M | $101.2M | $107.5M | $121.4M | $129.9M | $138.9M | $161.6M | $174.6M | $188.7M | $213.0M | $224.8M | $236.4M | $254.8M | |||
| Additional Paid In Capital | $1.83B | $1.93B | $2.01B | $2.15B | $2.22B | $2.26B | $2.32B | $2.32B | $2.36B | $2.38B | $2.38B | $2.37B | $2.37B | |||
| Stock Repurchased And Retired During Period Value | $105.4M | $84.8M | $65.3M | $71.3M | $48.6M | $49.7M | $6.3M | $41.2M | $22.2M | |||||||
| Dividends | $31.0M | $31.5M | $28.1M | $28.8M | $29.1M | $25.5M | $25.6M | $25.7M | $22.8M | $22.8M | $22.8M | |||||
| Other Noncash Income Expense | $0.00 | $8.0K | -$83.0K |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.